Lan Shen
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Food Science top 1%
- Proteins in Food Systems
- Microencapsulation and Drying Processes
- Polysaccharides Composition and Applications
Papers in
-
- Drug Solubulity and Delivery Systems 31
- Advanced Drug Delivery Systems 14
- Co-authors
- Yanlong Hong (54 shared papers)Chuan‐He Tang (4 shared papers)Yi Feng (50 shared papers)Xiao Lin (51 shared papers)Fei Wu (24 shared papers)Xiao Lin (25 shared papers)Jinxi Xiang (3 shared papers)Lijie Zhao (29 shared papers)
- Journals
- International Journal of Pharmaceutics (9 papers)RSC Advances (7 papers)International Journal of Biological Macromolecules (7 papers)Drug Delivery (5 papers)AAPS PharmSciTech (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lan Shen
186 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 174
- Pharmaceutical Science 583
- Food Science 838
- Rehabilitation 226
- Molecular Medicine 177
- Biomaterials 484
Countries citing papers authored by Lan Shen
This map shows the geographic impact of Lan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Shen more than expected).
Fields of papers citing papers by Lan Shen
This network shows the impact of papers produced by Lan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Shen. The network helps show where Lan Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 203 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 260 | |
| 2 | 2020 | 232 | |
| 3 | 2021 | 132 | |
| 4 | 2014 | 125 | |
| 5 | 2017 | 113 | |
| 6 | 2017 | 105 | |
| 7 | 2013 | 103 | |
| 8 | Determinants and outcomes of inpatient versus home based rehabilitation following elective hip and knee replacement. | 2000 | 78 |
| 9 | 2018 | 72 | |
| 10 | 2014 | 69 | |
| 11 | A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer. | 2021 | 65 |
| 12 | 2017 | 62 | |
| 13 | 2018 | 62 | |
| 14 | 2021 | 62 | |
| 15 | 2018 | 56 | |
| 16 | 2013 | 55 | |
| 17 | 2021 | 55 | |
| 18 | 2021 | 54 | |
| 19 | 2022 | 53 | |
| 20 | 2017 | 52 |
About Lan Shen
Lan Shen is a scholar working on Molecular Biology, Pharmaceutical Science, Plant Science, Complementary and alternative medicine and Food Science, having authored 203 papers that have together received 3.9k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (31 papers), Traditional Chinese Medicine Analysis (20 papers), Microencapsulation and Drying Processes (14 papers), Advanced Drug Delivery Systems (14 papers), Polysaccharides Composition and Applications (12 papers), Polysaccharides and Plant Cell Walls (11 papers), Pharmacological Effects of Natural Compounds (10 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Pharmaceutical Science (583 citations), Food Science (838 citations), Rehabilitation (226 citations), Molecular Medicine (177 citations) and Biomaterials (484 citations). Lan Shen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yanlong Hong, Chuan‐He Tang, Yi Feng, Xiao Lin, Fei Wu, Xiao Lin, Jinxi Xiang, Lijie Zhao, XU De-sheng and Miaomiao Zhou. Their work appears in journals such as International Journal of Pharmaceutics, RSC Advances, International Journal of Biological Macromolecules, Drug Delivery and AAPS PharmSciTech.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.